Home › Companies › DIANTHUS THERAPEUTICS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and DIANTHUS THERAPEUTICS INC.’s Form 8-K, filed May 22, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 22, 2025: 4 items on DIANTHUS THERAPEUTICS INC.’s Form 8-K, filed May 22, 2025: 2 approved · 2 passed (calculated).
Notable dissent: 1 director (12.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore DIANTHUS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are DIANTHUS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 22, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Marino Garcia | 23,703,737 | -- | -- | 2,122,220 | 1,996,674 | 92% | Passed (calculated) | — |
| Elect Director: Paula Soteropoulos | 22,695,868 | -- | -- | 3,130,089 | 1,996,674 | 88% | Passed (calculated) | — |
| 2. Advisory Vote on Executive Compensation | 22,132,031 | 3,684,797 | 9,129 | -- | 1,996,674 | 86% | Approved | — |
| 3. Ratification of Appointment of Independent Registered Public Accounting Firm | 27,812,736 | 1,706 | 8,189 | -- | -- | 99.9% | Approved | — |
Source: DIANTHUS THERAPEUTICS INC., Form 8-K, filed with the SEC on May 22, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
138 asset managers disclosed a vote on at least one DIANTHUS THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Marino Garcia
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Marino Garcia”): 23,703,737 for, 2,122,220 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 4,500,416 for, 61,710 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 557,585 | 0 | 0 | 0 | For |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 110,364 | 0 | 0 | 0 | For |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 50,573 | 0 | 0 | 0 | For |
| Equitable | 34,718 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 20,363 | Withhold |
| State Street | 17,492 | 0 | 0 | 20 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 0 | 8,062 | Withhold |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 6,432 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 5,324 | Withhold |
| ProShares | 0 | 0 | 0 | 4,757 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 4,375 | Withhold |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 3,559 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,342 | Withhold |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Paula Soteropoulos
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Paula Soteropoulos”): 22,695,868 for, 3,130,089 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 3,757,084 for, 805,042 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 557,585 | Withhold |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 110,364 | Withhold |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 50,573 | Withhold |
| Equitable | 9,908 | 0 | 0 | 24,810 | Mixed |
| American Century | 0 | 0 | 0 | 20,363 | Withhold |
| State Street | 17,492 | 0 | 0 | 20 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 0 | 8,062 | Withhold |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 6,432 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 5,324 | Withhold |
| ProShares | 0 | 0 | 0 | 4,757 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 4,375 | Withhold |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 3,559 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,342 | Withhold |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
86% Approved · of votes cast
Prior year: 99.9% for (May 23, 2024 meeting) ▼ 14.1 pts
Description as filed by funds: To approve, on an advisory basis, the compensation paid to our named executive officers; and
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“2. Advisory Vote on Executive Compensation”): 22,132,031 for, 3,684,797 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Advisory Vote on Executive Compensation The Company's stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers.”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 557,585 | 0 | 0 | Against |
| Vanguard | 0 | 446,119 | 0 | 0 | Against |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 0 | 110,364 | 0 | 0 | Against |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 50,573 | 0 | 0 | 0 | For |
| Equitable | 9,908 | 24,810 | 0 | 0 | Mixed |
| American Century | 0 | 20,363 | 0 | 0 | Against |
| State Street | 17,492 | 20 | 0 | 0 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 8,062 | 0 | Abstain |
| Goldman Sachs | 0 | 7,432 | 0 | 0 | Against |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 6,432 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 5,324 | 0 | 0 | Against |
| ProShares | 0 | 4,757 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 4,375 | 0 | 0 | Against |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 0 | 3,559 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,342 | 0 | 0 | Against |
Fund voting reports, all 42 managers: 3,352,575 for, 1,201,489 against, 8,062 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,053,342 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 2,866,733 | 0 | 0 | 0 | For |
| Fairmount Funds Management LLC | 2,700,691 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 2,341,667 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 2,341,613 | 0 | 0 | 0 | For |
| VR Adviser, LLC | 1,744,373 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 1,689,374 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 1,501,624 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 1,027,711 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 863,462 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 769,639 | 0 | 0 | Against |
| Catalio Capital Management, LP | 535,539 | 0 | 0 | 0 | For |
| Point72 | 0 | 481,235 | 0 | 0 | Against |
| Citadel | 441,364 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 381,054 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 275,000 | 0 | 0 | 0 | For |
| Janus Henderson | 0 | 262,148 | 0 | 0 | Against |
| State Street | 254,520 | 1,535 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 248,610 | 0 | 0 | Against |
| BlackRock | 240,033 | 5,282 | 0 | 0 | For |
| Woodline Partners LP | 237,555 | 0 | 0 | 0 | For |
| GV Management Company, L.L.C. | 208,697 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 189,000 | 0 | 0 | Against |
| Charles Schwab | 172,905 | 0 | 0 | 0 | For |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 134,003 | 0 | 0 | Against |
No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE, LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Public Accounting Firm”): 27,812,736 for, 1,706 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 4,554,064 for, 8,062 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 557,585 | 0 | 0 | 0 | For |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 110,364 | 0 | 0 | 0 | For |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 50,573 | 0 | 0 | 0 | For |
| Equitable | 34,718 | 0 | 0 | 0 | For |
| American Century | 20,363 | 0 | 0 | 0 | For |
| State Street | 17,512 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 8,062 | 0 | Abstain |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 6,432 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 5,324 | 0 | 0 | 0 | For |
| ProShares | 4,757 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 4,375 | 0 | 0 | 0 | For |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 3,559 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 2,342 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 32,125,933 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 9.28% |
| 2 | AllianceBernstein | 1.74% |
| 3 | Vanguard | 1.39% |
| 4 | Charles Schwab | 0.51% |
| 5 | Principal | 0.34% |
| 6 | BlackRock | 0.19% |
| 7 | Northern Trust | 0.16% |
| 8 | Equitable | 0.11% |
| 9 | American Century | 0.06% |
| 10 | State Street | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 12.62% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 8.92% |
| 3 | Fairmount Funds Management LLC | 8.41% |
| 4 | Octagon Capital Advisors LP | 7.29% |
| 5 | Deep Track Capital, LP | 7.29% |
| 6 | VR Adviser, LLC | 5.43% |
| 7 | Bain Capital Life Sciences Investors, LLC | 5.26% |
| 8 | TCG Crossover Management, LLC | 4.67% |
| 9 | 5AM Venture Management, LLC | 3.20% |
| 10 | AllianceBernstein | 2.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR (Fidelity) | 4,482,609 | 13.95% | Form 13F, quarter ended March 31, 2025 |
| Sirenia Capital Management LP | 2,798,122 | 8.71% | Schedule 13G, filed May 15, 2026 |
| RA Capital Management, L.P. | 2,611,733 | 8.13% | Schedule 13G, filed May 15, 2026 |
| Wellington Management Group LLP | 2,595,783 | 8.08% | Schedule 13G, filed May 15, 2026 |
| Fairmount Funds Management LLC | 2,139,635 | 6.66% | Schedule 13D, filed November 25, 2025 |
| Avidity Partners Management LP | 2,104,184 | 6.55% | Schedule 13D, filed November 19, 2025 |
| BlackRock | 1,615,801 | 5.03% | Form 13F, quarter ended March 31, 2025 |
| TCG Crossover GP II, LLC | 1,501,624 | 4.67% | Schedule 13G, filed May 15, 2025 |
| Point72 | 1,486,944 | 4.63% | Form 13F, quarter ended March 31, 2025 |
| BCLS Fund III Investments, LP | 1,315,892 | 4.10% | Schedule 13G, filed November 14, 2025 |
Percentages above are of 32,125,933 shares outstanding, as reported by DIANTHUS THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At DIANTHUS THERAPEUTICS INC.'s shareholder meeting held May 22, 2025, in the 2024-2025 proxy season, 138 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 621 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to our named executive officers; and — DIANTHUS THERAPEUTICS INC.'s filing reports the proposal as approved, with 86% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: DIANTHUS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 22, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DIANTHUS THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
DIANTHUS THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “DIANTHUS THERAPEUTICS (DNTH) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/dianthus-therapeutics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.